Shirong Peng

机构：Sun Yat-sen University, Zunyi Medical University, Sun Yat-sen Memorial Hospital, Guangzhou First People's Hospital, Guangzhou Medical University · ORCID：0000-0001-8905-3317

发表论文 28 篇 · 总被引 431 次 · h-index 11

代表论文

• GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer (2021 · Frontiers in Cell and Developmental Biology · 被引 58)
• The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling (2020 · Clinical and Translational Medicine · 被引 57)
• Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer (2021 · Cancer Biology and Medicine · 被引 52)
• B7 score and T cell infiltration stratify immune status in prostate cancer (2021 · Journal for ImmunoTherapy of Cancer · 被引 38)
• Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer (2024 · Journal of Advanced Research · 被引 28)
• Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer (2024 · International Journal of Biological Sciences · 被引 28)